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1. IntroductIon
Biomarkers are biological scale that can be measured and 
evaluated as an indicator of pathologic processes that indicates 
pharmacological response upon therapeutic Intervention.
Radiation biomarkers are specifically indicator of radiation 
doses absorbed by a radiation victim. Radiation biomarkers 
are also help to suggest the necessity of medical interventions 
such as countermeasure applications. Since, biomarkers are 
quantifiable in nature; they can be used to characterise indirect 
or direct drug performance, dose selection and potential safety 
issues related to candidate drug administration1. 
In   general   biomarkers   are   categorised as 
(a) Diagnostic biomarkers categorises a person by the presence 
or absence of a particular disease or physiological or 
pathophysiological state 
(b) Prognostic biomarker are those which categorises patients 
by level of risk for disease progression or occurrence and
(c) A predictive biomarker categorises patients by their 
likelihood of response to treatment with respect to no 
treatment. It can predict a favourable or adverse effect of 
a particular treatment2. 
Biological markers for human population for ionising 
radiation (IR) exposure are of great interest for analysing 
tissue injury in biodosimetry during nuclear incidents or 
accidents. The current approach for radiation biodosimetry 
include physical effects, such as time of action, kinetics of 
blood lymphocyte and assessment of cytogenetic damage in 
blood lymphocytes3,4. Limitations of these methods are they 
are time-consuming and thus not suitable for triage exposed 
persons during radiation eventuality.
2. GenomIc bIomarker of radIatIon 
dosImetry
Genomic analysis provides excellent tools to identify genes 
involved in DNA damage response and repair functions. DNA 
is sensitive towards radiation and serves as a critical cellular 
target and the potential of the cell to repair DNA damage 
determines its fate post exposure. Radiation induced damage in 
DNA damage by different means including DNA-protein cross-
links modulation, DNA Single strand breaks (SSBs), alteration 
in sugar and nitrogen backbone, bulky lesions formation i.e. 
clusters of base and sugar damage and double strand breaks 
(DSBs)5. The immediate effect of radiation induced DNA 
damage is activation of the DNA repair mechanism and 
the activation of cell cycle checkpoints, induction of down-
stream signalling for cellular responses such as apoptosis that 
removes damaged cells. The main repair mechanism is base 
excision repair (BER) that is responsible for the elimination 
of damaged bases and single-strand breaks in DNA by 
involvement of DNA polymerase and ligation of DNA 
ends6. Another major pathway to repair bulky DNA damages 
is Nucleotide excision repair (NER) that repairs helical 
distortion7. The proteins of NER are involved in repairing 
oxidative damage through activation of BER that includes 
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XPC (Xerodermapigmentosum, complementation group C) 
and XPG (Xerodermapigmentosum, complementation group 
G)8. There are several genes of NER which are up-regulated by 
radiation, including XPC and Damage Specific DNA binding 
protein 2 (DDB2)9,10. Ionising radiation is known to activate 
transcript and several components of cell cycle regulators 
i.e. CDKN1A (p21), Cyclin G1 (CCNG1), GADD45a, 
CHK2-thr68 and apoptosis regulating genes i.e. (BAX and 
BBC311-13. However, there is very less information regarding 
co-exposure of confounding factors that can affect the utility 
of individual biomarker of radiation biodosimetry14. The 
ex vivo model of human blood irradiation has been used to 
investigate the early radiation induced biological responses 
for potential biodosimetry applications4. There is a study 
that reports about the transcriptional response of well-known 
DNA repair, cell cycle and apoptosis regulating genes after 
irradiation 
With the advancement of high end DNA microarrays 
technique and next-generation Sequencing (NGS), screening 
and identification of radiation sensitive genes are possible. 
Recently there are several studies that have demonstrated the 
success and functional methodology involve in assessment of 
doses dependent gene expression levels in cellular models14-16. 
To analyse human dosimetry to determine the dose rate effect 
on the gene expression study was conducted using whole blood 
samples from individual which are exposed to acute radiation 
dose rate with low radiation dosages9. Among the sets of genes 
responded to low dose rate (LDR 0.56 Gy) were XPC, DDB2, 
POLH, GADD45A and PCNA. The findings suggested that the 
gene expression response in the cells exposed to LDR (0.56 
Gy) continuously to 24 h was different as compared to the 
cells which were exposed with acute exposure at 4.45 Gy. In 
the same study another 143 genes were identified that were 
sensitive towards radiation. Gene ontology analysis of these 
genes was revealed that there is enrichment of two processes: 
glycolysis and monosaccharide metabolic process. Genes 
involved in these two categories were the members of the 
glycolysis pathway (lactatedehydrogenase A, glyceraldehyde 
3-phosphatedehydrogenase, 6-phospho-fructokinase type C, 
enolase 1, and hexokinase 2. These genes were expressed 
at lower levels in the cells that exposed to protracted dose17. 
Another study that identified more than 20 genes that indicated 
gene expression response not much affected with the dose rate. 
There were up regulated i.e. AEN and CDKN1A and down 
regulated i.e. MyC and E2f5 gene in both LDR and acute 
exposure cases18.
There is another pattern of gene expression reported in 
which gene expression induced only in low dose radiation 
but not in acute exposure. There were two types of genes in 
this group, one in which the genes were up regulated by LDR 
only, but  not with acute doses (RBM3  and GRM2) and in 
another case, where  genes were down regulated by LDR only 
but  not with acute doses (DuSP3 and ID2, fig. 3)19. This 
preliminary assessment of differential gene expression with 
low dose rate radiation exposure suggested that there are genes 
that can be distinguish based on different dose-rate strength of 
applied radiation20. Interestingly, there are some genes such as 
APOBEC3H, fDXR and PHLDA3 that can induce at all doses 
by low dose rate and acute radiation exposure17. however, the 
change in gene expression beyond 4.45 Gy dose was higher in 
the acute exposure group as compared to LDR exposed groups 
of cells. 
3. ProteIn bIomarker for radIatIon  
    exPosure
3.1	 γ-H2AX
Radiation induced DNA double-strand break (DSB) 
is a cytotoxic form of DNA alteration. If this damage is 
not repaired correctly it can leads to genomic instability, 
chromosome aberrations and mutations21,22. A linear 
correlation was established in double strand breaks 
(DSBs) and radiation dose. It has been reported that 
1.0Gy of radiation induces approximately 20-40 DSBs 
per cell nucleus23. H2AX play a significant role in DNA 
damage repair. Phosphorylation of H2AX is mediated 
by the phosphoinositide-3-kinase-related kinase (PIKK) 
family members ATM and DNA-PK following ionising 
irradiation24. Whereas, ATR and DNA-PK appear to be 
involved in γ-H2AX formation at the sites of replication-
associated breaks25. The measurement of γ-H2AX foci is 
done following low radiation exposure as 1 mGy, and foci 
yields have been shown to increase linearly with increasing 
radiation doses22. Scoring of foci is the most sensitive 
method for γ-H2AX analysis. A single DSB results in the 
phosphorylation of thousands of H2AX proteins molecules 
over chromatin domain of several mega bases of DNA 
either side of the break. 
figure.1 radiation induced gene biomarker. up regulated nucleotide 
excision repair genes (xPc, xPG, ddb2), apoptotic genes 
(BAX,	 BBC3)	 and	 cell	 cycle	 genes	 (CDKN1,	GADD45α,	
cyclin G1). 
figure 2. radiation dose response related expression of genes. Genes 
responding to 1 Gy and  genes responding on more than 
5 Gy exposure. 
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3.2	 Amylase,	 Flt3-ligand	 and	 C-reactive	 Protein	 as	
Bio-indicator	 of	 Radiation	 Damage
Reduction in amylase level is considered as a direct 
indicator of radiation-induced damage of the parotid gland. 
While flt3-ligand, a hematopoietic cytokine, is considered 
as bio-indicator of bone marrow damage26. Both of these 
parameters are relatively easy to analyse quantitatively in 
serum/plasma using a clinical blood chemistry analyser 
or using ELISA27. The variation in the level of C-reactive 
protein level, (secreted component by hepatocytes cells during 
inflammation), presents an accurate measurement of the degree 
of systemic inflammation. It is not only specific to radiation 
exposure but it can be modulated in case of cancer, rheumatoid 
arthritis and cardiovascular diseases28.
3.3 cytokines, chemokines, and other Proteins
In the recent time cytokines and chemokines are 
considered a sensitive biomarker of radiation exposure. G-CSf 
has been reported to be up-regulated in irradiated mouse and 
non-human primates (NHPs) and plays an important role 
in ameliorating radiation injury29-32. Additionally, several 
cytokines, chemokines and other proteins have been identified 
as candidate biomarkers of radiation injury over the last few 
years, as tested in total-body and partial-body exposure situation 
in murine and NhP models33-36. Among all, interleukin-6 
(IL-6), C-reactive protein (CRP), serum amyloid A (SAA), 
growth arrest and DNA damage-inducible 45 (GADD45) 
proteins, fMS-like tyrosine kinase 3 ligand (flt3L) and salivary 
α- amylase are some prominent members of radiation sensitive 
proteins biomarkers. Previously, interleukin-18 (IL-18) has 
been reported up-regulated at 5–10 Gy60Co γ-irradiation. IL-18 
serum concentrations are also correlated with radiation dose in 
mini-pigs, NhPs, and mice 37.
3.4 Peripheral blood counts
There are several studies that use peripheral blood cell 
counts as radiation biomarker of post irradiation situation. The 
cells analysed are granulocytes, lymphocytes, leukocytes, and 
platelets. Peripheral blood cell counts test has significance as 
it correlate radiation dose exposure not restricted at early time 
points (1 day or 2 days) but can be extended to the late phase 
(up to 4 weeks) after radiation exposure38. Peripheral blood cell 
counts have been used to monitor the health of the victims of 
radiation related accidents, support the use of this parameter as 
a diagnostic tool39. 
4. cytoGenetIc bIomarkers
4.1 dicentrics
Dicentric chromosomes (i.e. chromosomes with two 
centromeres) are induced by ionising radiation. They 
are substantially stable within non-dividing cells such as 
lymphocytes. The stability (half-life) of blood lymphocytes 
in order of months/years depends upon the sub-population40, 
thus the dicentric exists as biomarker of choice for radiation 
exposure. using dicentric assay, individual dose assessment 
can be established in the victims exposed with whole-body 
radiation exposure as low as 100 mGy. Since, the dicentric 
assay is very tedious, expertise oriented and time consuming, 
it may not the choice of diagnosis during mass radiation 
exposure to general public. Continuous efforts have been 
made to develop an automated system to provide reproducible 
results within short period of time41. In continuation to acute 
whole-body exposures the dose estimation for partial-body and 
protracted exposure can be achieved by scoring dicentrics in 
lymphocytes. 
4.2 Premature chromosome condensation
Premature chromosome condensation (PCC) is technique 
can be used to condense the chromosomes in quiescent 
and42. In process to cycling cells, it is possible to score ring 
chromosomes, dicentrics and translocations, if the PCC assay 
and fISH is combined together with chromosome painting or 
c-banding43,44. PCC has been considered as the most useful 
technique for assessing high dose acute exposures of low 
LET radiation45,46. PCC technique is successfully utilised in 
assessing some cases of exposure, especially for the problems 
of the radioprotection and assessment of received doses after 
medical imaging (X-ray and nuclear medicine)47. 
4.3 telomere Length
Telomeres are heterochromatic region composed of 
DNA repeats (TTAGGG) that binds to an array of specialised 
proteins which is situated at the end of chromosomes. Length 
of the repeats of telomere and the integrity of telomere 
binding proteins (TBP), these both are important for telomere 
protection48. Radiation exposure was known to be impaired 
telomere function that can lead to genomic instability, 
cancer progression, genetic instability, increased radiation 
sensitivity, loss of cellular viability and senescence49. It is 
has been reported earlier that short telomeres participates in 
inducing genomic instability in the aged progeny of irradiated 
cells50. The telomere length modulates chromosome in vitro 
radiosensitivity in healthy individuals51. The analysis of the 
telomere lengths in the study of persons exposed to radiation 
shows potential to exist as a radiation biomarker52.
4.4 micronuclei
Micronuclei are formed when the intact chromosomes 
or fragments are not properly separated to daughter nuclei 
during anaphase rather it remains in the cytoplasm after cell 
division. It could be visualised as a small spherical objects 
using conventional DNA dye53,54. Such analysis could be 
made on fresh blood or frozen peripheral blood lymphocytes55. 
Micronuclei analysis by cytokinesis-blocked micronucleus 
(CBMN) assay exhibits a great potential as a biomarker for 
individual’s radiosensitivity56.
4.5 metabolic biomarker
Radiation metabolomics is considered as the chemical 
fingerprinting of biological fluids to identify latent, 
endogenous small molecules having altered concentrations 
in a dose-dependent manner following radiation exposure57. 
Responding to the potential threat of nuclear and radiological 
terrorism Centre for High-Throughput Minimally Invasive 
Radiation Biodosimetry (CMCR) was established to develop 
biodosimeters which are field-deployable.
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A study performed on the mice which were irradiated and 
urine samples were analysed on 1H NMR (proton NMR). Profile 
of urine samples revealed the presence of lactate, alanine, 
glutamine, glutamate and alanine some other metabolites like 
hippurate, taurine, trimethyl amine (TMA), a-ketoglutarate 
(α-KG) and 2-ketoisocaproate were also present (fig. 3)58. 
NMR profiling of serum of irradiated mice was characterised 
by the predominance of lipids along with creatine, amino acids 
and organic acids59. Comparative analysis revealed about 
the significant changes were observed mainly in metabolites 
associated with energy metabolism (succinate, a-KG, citrate), 
gut flora metabolites [hippurate, TMA], osmolytes (betaine, 
sarcosine), amino acids (branched chain amino acids, 
isoleucine, phenylalanine, taurine) and creatinine in urine 
samples (fig. 3) of irradiated mice60. further, alteration in 
different metabolites at different phases of radiation sickness 
were found and reported, dramatic change in metabolic profile 
was reported at post irradiation time with significant increase in 
almost all metabolites61. On the other hand, metabolic changes 
observed in the serum were branched chain amino acid, lipids 
and lactate62. Some of the membrane metabolites viz., choline 
and phosphoethanolamine were increased only during post 
irradiation63. Most of the metabolites in the serum and urine of 
irradiated animals were found to be increased after sub lethal 
dose of whole body radiation. Most of the changes observed in 
urine were Kreb’s cycle intermediates along with other energy 
metabolites64. After radiation exposure, the bioenergetic status 
of the body might have resulted from increased energy demands 
and were, therefore, suggestive of changes in energy metabolism 
(fig. 3) after radiation exposure53. Interestingly, longer chain 
acylcarnitines (tetradecadienylcarnitine, octadecenoylcarnitine, 
and octadecadienylcarnitine were found to be decreased 
upon IR exposure. Carnitine was present in the highest 
abundance followed by acetylcarnitine, propionylcarnitine, 
butyrylcarnitine, and valerylcarnitine respectively65-67. 
Conversely, increases of long-chain acylcarnitines at higher 
IR doses may be due to increased IR induced apoptosis of 
bone marrow during hematopoietic syndrome68. Carnitine, 
acetylcarnitine, and butyrylcarnitine were also found to increase 
in irradiated NHP urine with carnitine and acylcarnitine in 
urine which were much higher than were observed in serum65. 
Significant increase in lipid peroxidation biomarkers have 
been observed at post-irradiation69. Global profiling indicated 
an increase in polyunsaturated lipids attributed to enhance of 
arachidonic and docosahexaenoic acid63.
5. concLusIons
Biomarkers are defined as the outcome of the repurcations 
associated with a particular disease and disorder. Specific 
biomarker is used to screen, diagnose, prognose, predict the 
disease initiation, progression and recurrence70. There are no 
set specific standards or criteria for development and validation 
of specific biomarker71. Exposure to ionising radiation (IR) 
can cause deleterious biological effects in humans (fig. 4). 
figure 4. concept image of radiation biomarker and its role in diagnostic and therapeutic. Graphical representation of radiation 
induced damage and changes in the system and role of biomarker in early detection and treatment.
figure 3. radiation induced metabolic biomarkers. Ir induced changes in components of urine, osmolytes, amino acids, components 
of energy metabolism, long chains carnitine and poly unsaturated lipids 
α
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Therefore, there is an urgent need to develop radiation 
biomarkers indicative of early and delayed whole body and 
organ-/tissue-specific injury that may facilitate the clinical 
management of afflicted populations.
6. summary
Radiation exposure has become an important concern 
for human beings in everyone’s daily life, because a person 
may receive irradiation from many different sources. Hence 
a suitable biomarker to analyse and measure the pathological 
manifestations and response to therapeutic interventions 
are necessity. Biomarker could be of any type diagnostic or 
prognostic or predictive based upon our interest in assessing 
tissue injury. In the cellular milieu DNA is the critical target 
for radiation induced damage.  The activation of the pathway 
related to DNA repair activates the pathway related to cell 
cycle check points and leading to apoptosis. Some of the cell 
cycle regulators like CDK, GADD45, Cyclin G1 and CHK-2 
serve as the genetic biomarker. Amylase, flt3 ligand, CRP and 
γ-H2AX are protein biomarker that provides the estimation of 
systemic inflammation. In the recent time several cytokine and 
chemokines have been identified as candidate biomarker for 
radiation injury such as IL-6, IL-18 and G-CSf. Chromosomal 
abbreviation induced by ionising radiation serves as biomarker 
for radiation exposure. formation of Dicentrics, Premature 
chromosome condensation and formation of micronuclei 
are promising radiation biomarker for individual radiation 
sensitivity. In the current scenario metabolic biomarker have 
been identified by chemical profiling through NMR and 
Mass spectroscopy of biofluid that gives the dose dependent 
concentration profile of endogenous small molecules. Some 
of the know metabolites like lactate, alanine, glutamine, 
glutamate, alanine, α-ketoglutarate and 2-ketoisocarporate are 
validated metabolic biomarker. 
7. future dIrectIon 
use of advanced mathematical, statistical, and 
computational modelling for evaluation of large datasets 
generated from multiple clinical and molecular parameters 
to understand radiation biology has already been established. 
Now technological advances in detection, acquisition, and 
processing have made the metabolomics platform a reliable 
source of data collection, there is still however, an urgent need 
for standardisation of protocols and analytical methods to 
validate these biomarkers and enable their use in the clinical or 
translational science settings. Careful and systematic collection, 
processing and storage of bio fluids are critical for downstream 
metabolomic studies for validation of research findings across 
institutions and for future systems biology analyses.
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